Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Roberto D'Amico a Mario Negri Institute for Pharmacological
Research, 20157 Milan, Italy, b Maggiore Ospedale
IRCCS, 20122 Milan
Correspondence to: Dr A
Liberati, Italian Cochrane Centre, Laboratory of Health Services
Research, Mario Negri Institute, Via Eritrea 62, 20157 Milan, Italy
Cochrane{at}irfmn.mnegri.it
Objective: To determine whether antibiotic
prophylaxis reduces respiratory tract infections and overall mortality
in unselected critically ill adult patients.
Design: Meta-analysis of randomised controlled trials
from 1984 and 1996 that compared different forms of antibiotic prophylaxis used to reduce respiratory tract infections and mortality with aggregate data and, in a subset of trials, data from individual patients.
Subjects: Unselected critically ill adult patients;
5727 patients for aggregate data meta-analysis, 4343 for confirmatory meta-analysis with data from individual patients.
Main outcome measures: Respiratory tract infections
and total mortality.
Results: Two categories of eligible trials were
defined: topical plus systemic antibiotics versus no treatment and topical preparation with or without a systemic antibiotic versus a
systemic agent or placebo. Estimates from aggregate data meta-analysis of 16 trials (3361 patients) that tested combined treatment
indicated a strong significant reduction in infection (odds ratio 0.35; 95% confidence interval 0.29 to 0.41) and total mortality (0.80; 0.69 to 0.93). With this treatment five and 23 patients would need to be
treated to prevent one infection and one death, respectively. Similar
analysis of 17 trials (2366 patients) that tested only topical
antibiotics indicated a clear reduction in infection (0.56; 0.46 to 0.68) without a significant effect on total mortality (1.01;
0.84 to 1.22). Analysis of data from individual patients yielded
similar results. No significant differences in treatment effect by
major subgroups of patients emerged from the analyses.
Conclusions: This meta-analysis of 15 years of
clinical research suggests that antibiotic prophylaxis with a
combination of topical and systemic drugs can reduce respiratory
tract infections and overall mortality in critically ill patients.
This effect is significant and worth while, and it
should be considered when practice guidelines are
defined.
Key messages
Read all Rapid Responses